(0.27%) 5 475.09 points
(0.13%) 39 170 points
(0.83%) 17 879 points
(0.14%) $83.50
(-0.24%) $2.47
(0.13%) $2 342.00
(0.41%) $29.74
(0.39%) $992.60
(0.05%) $0.931
(0.16%) $10.66
(0.04%) $0.791
(-0.01%) $86.75
Live Chart Being Loaded With Signals
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications...
Stats | |
---|---|
Today's Volume | 1.11M |
Average Volume | 0 |
Market Cap | 0.00 |
EPS | $-0.000500 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0300 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0680 (17.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-22 | Kelly Leanne | Buy | 83 333 | Stock Option (Right to Buy) |
2023-08-10 | Szekeres David Leslie | Buy | 34 483 | Stock Option (Right to Buy) |
2023-08-10 | Simpson Camilla V | Buy | 34 483 | Stock Option (Right to Buy) |
2023-08-10 | Rongen Roelof | Buy | 34 483 | Stock Option (Right to Buy) |
2023-08-10 | Baker David Charles | Buy | 34 483 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
96.84 |
Last 43 transactions |
Buy: 1 581 385 | Sell: 149 455 |
Volume Correlation
Vallon Pharmaceuticals Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vallon Pharmaceuticals Correlation - Currency/Commodity
Vallon Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.290 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.290 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.710 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.420 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Vallon Pharmaceuticals
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators